Fluxus, Inc.

Santa Clara, CA · Medtech · Acquired

Optofluidic single-molecule diagnostic instrument for tuberculosis detection via urine-based LAM immunoassay

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Santa Clara, CA
Total capital
$230K
Federal grants
$230K
1 award · 2021
Rank in peer group#277 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
10 pending · first 2022
Rank in peer group#33 of 542

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $230K$230K
2021FEDERAL ↑EQUITY ↓Cumulative $230K$230K

Latest events

  • Federal grantHealth and Human S · Phase I · Ultrasensitive Detection of Urine LAM for Point-of-Care Diagnosis of All Forms of Tuberculosis$230K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#33 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 6 granted of 16
Show all 16 patent records
  • Waveguide Structure With Aperture ArraySep 29, 2026 · US 12,748,261Granted
  • Measurement System And Measurement MethodOct 2, 2025 · Application 18619388Pending
  • Fabrication Of Waveguide StructuresSep 23, 2025 · US 12,422,619Granted
  • Alignment Of Photonic System Components Using A Reference SurfaceSep 9, 2025 · US 12,411,291Granted
  • Optofluidic DevicesJul 24, 2025 · Application 19034974Pending
  • Optofluidic DevicesMar 4, 2025 · US 12,242,107Granted
  • Fabrication Of Waveguide StructuresDec 26, 2023 · US 11,852,869Granted
  • Waveguide Structure With Aperture ArrayApr 27, 2023 · Application 17918039Pending
  • Fabrication Of Waveguide StructuresOct 25, 2022 · US 11,480,733Granted
  • Alignment Of Photonic System Components Using A Reference SurfaceApplication PCTUS2021016606Pending
  • Waveguide Structure With Aperture ArrayApplication 63013168Pending
  • Alignment Of Photonic System Components Using A Reference SurfaceApplication 62970018Pending
  • Fabrication Of Waveguide StructuresApplication PCTUS2019033365Pending
  • Fabrication Of Waveguide StructuresApplication 62674853Pending
  • Optofluidic DevicesApplication PCTUS2022077814Pending
  • Waveguide Structure With Aperture ArrayApplication PCTUS2021028234Pending
  • INVOTEK, INC.Similar federal contract value in Medtech · null in contracts
  • ORGANICNANO INCSimilar federal contract value in Medtech · null in contracts
  • Onocor LLCSimilar federal contract value in Medtech · null in contracts
  • ENCLEAR THERAPIES, INC.Similar federal contract value in Medtech · null in contracts
  • APC AVE 20, LLCSimilar federal contract value in Medtech · null in contracts
  • BIOVIDRIA, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .